Skip to main navigation Skip to search Skip to main content

Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: A phase I/II trial

  • Huijing Wang
  • , Ting Li
  • , Fangfang Sun
  • , Zhe Liu
  • , Danting Zhang
  • , Xiangyu Teng
  • , Laurence Morel
  • , Xiaodong Wang
  • , Shuang Ye

Research output: Contribution to journal › Article › peer-review

47   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: A phase I/II trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science